A critical advance in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in many forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research